Metabolic control during the first two years of the COVID-19 pandemic in pediatric patients with type 1 diabetes: results from the German DPV initiative.
Johanna HammersenSascha R TittelSemik KhodaverdiFelix ReschkeMonika FluryUlrike MenzelKirsten MönkemöllerThomas MeissnerBeate KargesReinhard W HollPublished in: Acta diabetologica (2023)
We found no clinically relevant change of glycemic control or incidence of acute diabetes complications during the pandemic. The observed BMI increase may represent an important health risk for youth with T1D.
Keyphrases
- glycemic control
- health risk
- type diabetes
- risk factors
- liver failure
- heavy metals
- blood glucose
- drinking water
- sars cov
- coronavirus disease
- quality improvement
- respiratory failure
- weight loss
- body mass index
- physical activity
- mental health
- insulin resistance
- drug induced
- young adults
- aortic dissection
- weight gain
- cardiovascular disease
- risk assessment
- metabolic syndrome
- adipose tissue
- intensive care unit